Yearly CT scans aim to catch lung cancer early in mexican smokers and Wood-Smoke exposed
NCT ID NCT06535451
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will give yearly low-dose CT scans to 1,000 people in Mexico who are at high risk for lung cancer—including heavy smokers, former smokers, and those exposed to wood smoke. The goal is to see if regular screening can find lung cancer at an earlier, more treatable stage. Participants will also have lung function tests and blood tests over three years, with follow-up lasting up to 10 years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- low-dose computed tomography (LDCT) scan
- What this could lead to
- If successful, this could show that annual LDCT screening helps catch lung cancer earlier in high-risk populations, potentially improving survival rates.
- What could go wrong
- This is an observational screening study, not a treatment trial. It may not prove that screening reduces deaths, and false positives could cause unnecessary anxiety or procedures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Instituto Nacional de Cancerologia (INCan) Mexico
RECRUITINGMexico City, Tlalpan, 14080, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Your Tumor's DNA might predict immunotherapy success
- Can a new PET tracer light up hidden cancers?
- Fellow veterans may hold the key to earlier lung cancer detection